Oncologist Dr. Chistine Bestvina addresses therapeutic and supportive care priorities for patients with progressive metastatic non-small cell lung cancer.

Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Even in early-stage disease, the recurrence rate for non-small cell lung cancer can be as high as 30 to 50 percent. Hear from oncologist Dr. Christine Bestvina on how she manages patients with recurrent disease.

Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Determining how to treat your non-small cell lung cancer patients is a critical part of their care. Joining us to explore treatment modalities for her patients based on their cancer stage is Dr. Christine Bestvina, an oncologist and Assistant Professor of Medicine at the University of Chicago.

Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

The lingering fear of CT-based screenings delivering false positives has caused many challenges, but that doesn’t mean achieving accurate diagnostic staging with our non-small cell lung cancer patients is impossible. To prove it, Dr. Erin Schenk walks through the steps she takes to determine a patient’s stage of cancer and how it impacts her treatment approach.

Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Through prevention recommendations and various diagnostic tools, the ability to detect non-small cell lung cancer (NSCLC) early and, by extension, dramatically improve a patient’s quality of life is now achievable. And here to walk Dr. Jennifer Caudle through all of that is Dr. Erin Schenk, an Assistant Professor of Medical Oncology at the University of Colorado.

Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Dr. Christine Bestvina, Assistant Professor of Medical Oncology at the University of Chicago, retells the case of one non-small cell lung cancer patient whose need for a change in treatment course halfway through proved to be rewarding for both her and her patient.

Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Highlighting the new guidelines brought forth by the National Comprehensive Cancer Network is Dr. Christine Bestvina, Assistant Professor of Medical Oncology from the University of Chicago. With this new and important information in mind, she explores how these modifications will impact the way we approach caring for our patients with non-small cell lung cancer.

Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Family physician Dr. Jennifer Caudle and oncologist Dr. Christine Bestvina come together to take on the many questions surrounding care coordination in non-small cell lung cancer. Addressing a variety of topics like the various physicians involved and the challenges often encountered, Dr. Bestvina reveals the key strategies of seamless multidisciplinary teams to help you improve patient outcomes.

Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Flipping the term “aggressive” on its head is Dr. Everett Vokes from the University of Chicago. Dr. Vokes unveils the term “intensive therapy” to describe his approach to aggressive NSCLC management and provides us with his rationale behind implementing this approach into practice.

Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

With no one patient being the same, there’s a lot to consider when developing a treatment plan for advanced non-small cell lung cancer, and complex cases, such as elderly patients, can bring considerable uncertainty. Dr. Everett Vokes dives into the strategies he uses to guide his decisions when he’s faced with a challenging case.

Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.